[1]
Drakenberg Danese, M.B. et al. 2026. PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set. Acta Oncologica. 65, (May 2026), 401–405. DOI:https://doi.org/10.2340/1651-226X.2026.45589.